There are currently 66 ongoing clinical trials involving Oligodendroglioma
Of the 66 trials,23 trials are in Phase II
Furthermore, 21 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Oligodendroglioma, an Oncology condition. The largest number of ongoing clinical trials for Oligodendroglioma is conducted in the North America region. Asia-Pacific and Europe are among some of the other prominent regions engaged in Oligodendroglioma-related drug trials.
St. Jude Children’s Research Hospital Inc: The leading ongoing Oligodendroglioma related clinical trial sponsor
St. Jude Children’s Research Hospital Inc is the top sponsor for Oligodendroglioma-related ongoing clinical trials.
Memorial Sloan Kettering Cancer Center, Novartis AG, University of California San Francisco and Beijing Sanbo Brain Hospital are among other notable clinical trial sponsors involved in Oligodendroglioma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
Marketed Drugs involving Oligodendroglioma
Carmustine (Bicnu, Becenun, Carmubris, Carmustine Avet), Procarbazine (Matulane / Natulan) and Vincristine sulfate (Oncovin) are among the key marketed drugs involving Oligodendroglioma.
Carmustine (Bicnu, Becenun, Carmubris, Carmustine Avet) acts as an alkylating agent. It functions via DNA Synthesis Inhibitor mechanism of action. Carmustine is formulated as lyophilized powder for solution and solution for intravenous route of administration. Carmustine was first approved in 1975 and is marketed globally in the US, UK, Australia, Canada, Germany, and France by several prominent pharma giants including Avet Pharmaceuticals Inc.
Procarbazine (Matulane / Natulan) is a benzamide derivative acts as anti-neoplastic agent. It functions via DNA Synthesis Inhibitor mechanism of action. Procarbazine is formulated as hard gealtin capsules for oral route of administration. Procarbazine was first approved in 1965 and is marketed globally in the US, France, Germany, Russia and Japan by several prominent pharma giants including Leadiant Biosciences Inc.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer